Inhibition of Agrobacterium-induced necrosis - actual pending claims
Patent application filed by Novartis
Actual pending claims
|
EP 986 299 A2 |
|---|
| Claim 1
A method of transforming a plant cell with a gene of interest, comprising
|
| Claim 8
A method of making a fertile, transgenic plant comprising: A) transforming
plant tissue by exposing the tissue to Agrobacterium under conditions
which inhibit Agrobacterium- induced necrosis (AIN); and |
| Claim 9
A plant, plant tissue or plant cell comprising a nucleotide sequence of heterologous origin which inhibits AIN. |
| Claim 10
A plant cell or tissue culture medium, comprising: |
| Claim 11
A method of transforming a totipotent cell of a plant of the family Gramineae, comprising
|
| Claim 12
A method for determining the suitability of an Agrobacterium strain
for use in the transformation of a regenerable cell of a plant of the family
Gramineae comprising: A) exposing a population of said regenerable cells of the
plant to the Agrobacterium strain; and |
| Claim 13
An Agrobacterium strain which has been genetically modified to reduce or eliminate expression of the Agrobacterium necrosis factor or a derivative of such a modified strain. |
The information contained in this page was believed to be correct at the time it was collated. New patents and patent applications, altered status of patents, and case law may have resulted in changes in the landscape. CAMBIA makes no warranty that it is correct or up to date at this time and accepts no liability for any use that might be made of it. Corrections or updates to the information are welcome. Please send an email to info@bios.net.



There are no comments.